Alligator Bioscience AB (ATORX) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Saniona AB

Vimian Group AB

Probi AB

Biovica International AB

Intervacc AB

BioInvent International AB

BICO Group AB

Alligator Bioscience AB

Magle Chemoswed Holding AB

Mendus AB

Bio-Works Technologies AB

Why is Alligator Bioscience AB ?

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

Poor long term growth as Net Sales has grown by an annual rate of 57.57% and Operating profit at 1.18% over the last 5 years
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -108.20

Flat results in Jun 25

CASH AND EQV(HY) Lowest at SEK 62.75 MM
INTEREST(Q) Highest at SEK 17.5 MM

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -92.92%, its profits have risen by 38.5%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -92.92% returns in the last 1 year, the stock has also underperformed OMX Stockholm 30 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Alligator Bioscience AB for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Alligator Bioscience AB

-92.92%

-0.00

99078.38%

OMX Stockholm 30

8.01%

0.44

18.11%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

57.57%

EBIT Growth (5y)

1.18%

EBIT to Interest (avg)

-108.20

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.20

Sales to Capital Employed (avg)

-0.40

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-5.39

EV to EBIT

-0.79

EV to EBITDA

-1.01

EV to Capital Employed

-2.76

EV to Sales

3.77

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

Negative BV

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bullish

Bearish

OBV

Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

16What is working for the Company

OPERATING CASH FLOW(Y)

Highest at SEK -161.23 MM

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

NET SALES(9M)

Higher at SEK 41.78 MM

PRE-TAX PROFIT(Q)

At SEK -13.9 MM has Grown at 69.03%

NET PROFIT(Q)

At SEK -13.9 MM has Grown at 69.03%

EPS(Q)

Highest at SEK -0.08

-12What is not working for the Company

CASH AND EQV(HY)

Lowest at SEK 62.75 MM

INTEREST(Q)

Highest at SEK 17.5 MM

Here's what is working for Alligator Bioscience AB

Net Sales

At SEK 41.78 MM has Grown at 58.9%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (SEK MM)

Operating Cash Flow

Highest at SEK -161.23 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (SEK MM)

Pre-Tax Profit

At SEK -13.9 MM has Grown at 69.03%

over average net sales of the previous four periods of SEK -44.87 MM

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (SEK MM)

Net Profit

At SEK -13.9 MM has Grown at 69.03%

over average net sales of the previous four periods of SEK -44.87 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (SEK MM)

EPS

Highest at SEK -0.08

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (SEK)

Net Sales

Higher at SEK 41.78 MM

than preceding 12 month period ended Jun 2025

MOJO Watch

In the nine month period the company has already crossed sales of the previous twelve months

Net Sales (SEK MM)

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Alligator Bioscience AB

Interest

At SEK 17.5 MM has Grown at 26.98%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (SEK MM)

Interest

Highest at SEK 17.5 MM

in the last five periods and Increased by 26.98% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (SEK MM)

Cash and Eqv

Lowest at SEK 62.75 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents